Breathe Well Live Well
|
Despite Generic Erosion of Current Market Leaders, the Asthma Market Will …
MarketWatch BURLINGTON, Mass., Sept. 22, 2015 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain relatively flat, increasing slightly from $15.9 billion in 2014 to $16.2 billion in 2024 across the seven major markets (the United … |
View full post on asthma – Google News
The Pharma Letter |
Asthma market to remain stable over next decade, despite generic erosion
The Pharma Letter New market potential in underserved asthma population: Emerging anticytokines that are predicted to launch during the next decade will serve part of the unmet need in the severe, refractory asthma population, which is currently served by only systemic … |
View full post on asthma – Google News
|
In the Asthma Drug Market, Generic Erosion Will Reduce Sales of Merck/Kyorin's …
Business Wire (press release) The upcoming Pharmacor advisory service entitled Asthma, which will be published soon, also finds that the overall market for asthma therapies will be relatively flat over the next decade, with sales increasing slightly by approximately $200 million … |
View full post on asthma – Google News
|
In the Asthma Drug Market, Generic Erosion Will Reduce Sales of Merck/Kyorin's …
MarketWatch (press release) The upcoming Pharmacor advisory service entitled Asthma, which will be published soon, also finds that the overall market for asthma therapies will be relatively flat over the next decade, with sales increasing slightly by approximately $200 million … |
View full post on asthma – Google News
|
Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion …
BioMedReports (subscription) The overall asthma drug market will decrease slightly from $14.6 billion in 2010 to $14.4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. “Driving these sales will be the uptake of emerging once-daily … Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion … |
View full post on asthma – Google News
|
Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion …
MarketWatch (press release) The overall asthma drug market will decrease slightly from $14.6 billion in 2010 to $14.4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The Pharmacor advisory service entitled Asthma finds that the … |
View full post on asthma – Google News